BACK
GLOBAL EXECUTIVE MOVES

May 2021
Sparrow Pharmaceuticals, Inc Appoints Robert Jacks as Chief Executive Officer of the Company
Sparrow Pharmaceuticals, Inc announced the appointment of biopharmaceutical industry veteran Robert Jacks as Chief Executive Officer of the company.
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess – associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. It is privately held and based in Portland, Oregon.